Status:
COMPLETED
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
American Cancer Society, Inc.
Conditions:
Leukemia
Acute Leukemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover phys...
Detailed Description
This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and mul...
Eligibility Criteria
Inclusion
- Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed
- Be at least 18 years old now (and at least 16 when they had their transplant)
- Speak English
- Have telephone service
Exclusion
- None
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
315 Patients enrolled
Trial Details
Trial ID
NCT00701844
Start Date
July 1 2007
End Date
September 1 2011
Last Update
November 17 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601-1991
2
Mount Sinai School of Medicine
New York, New York, United States, 10029
3
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599-6011